TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.50$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

MannKind Corp (MNKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 109 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MNKD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
51 58 66 72 70 77 78 77 82 112 90 109 394
14 18 19 20 18 20 18 21 20 24 22 30 96
37 40 48 52 52 57 61 56 62 88 68 80 298
10.0 9.2 10 12 13 11 11 14 14 28 17 18 77
11 9.5 11 13 11 34 25 32 14 58 54 58 185
32 33 31 35 39 31 39 51 43 96 71 80 290
5.1 7.9 17 17 13 26 22 5.3 19 -7.7 -3.0 -0.4 7.8
5.3 5.4 9.3 13 8.4 7.5 11 6.2 7.3 13 12 12 45
1.7 3.0 11 -1.7 13 8.4 14 0.9 7.8 -21 -16 -19 -49
5.6 1.6 0.3 0.3 1.3 1.0 0.5 0.3 -0.2 -5.0 0.3 -0.1 -5.0
1.7 1.4 11 -2.0 12 7.4 13 0.7 8.0 -16 -17 -19 -44
8.4 9.9 22 13 24 19 27 9.7 18 -2.5 2.5 13 31

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?